High antibody titers against apolipoprotein-A1 in NAFLD: a possible link between fatty liver disease and CVD?

Pagano, Sabrina; Alfaiate, Dulce; Juillard Mochon, Catherine; Frias, Miguel; Magenta, Alessandra; Martino, Francesco; Sciacqua, Angela; Succurro, Elena; Burger, Fabienne; Brandt, Karim; Andreozzi, Francesco; Mach, François; Perticone, Maria; Vuilleumier, Nicolas

doi:10.1016/j.atherosclerosis.2022.06.065

Conference presentation

English

High antibody titers against apolipoprotein-A1 in NAFLD: a possible link between fatty liver disease and CVD?

ContributorsPagano, Sabrina

; Alfaiate, Dulce; Juillard Mochon, Catherine; Frias, Miguel

; Magenta, Alessandra; Martino, Francesco; Sciacqua, Angela; Succurro, Elena; Burger, Fabienne; Brandt, Karim; Andreozzi, Francesco; Mach, François; Perticone, Maria; Vuilleumier, Nicolas

Presented at90th European Atherosclerosis Society (EAS) congress, Milan (Italy), May 22-25, 2022

Presentation date2022-05-24

Notepublié dans Atherosclerosis, Volume 355, August 2022, Page 24.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Citation (ISO format)

PAGANO, Sabrina et al. High antibody titers against apolipoprotein-A1 in NAFLD: a possible link between fatty liver disease and CVD? In: 90th European Atherosclerosis Society (EAS) congress. Milan (Italy). 2022. doi: 10.1016/j.atherosclerosis.2022.06.065

Summary - version publiée dans la revue

Summary - version dans le programme

Identifiers

PID : unige:167617
DOI : 10.1016/j.atherosclerosis.2022.06.065

Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S0021915022003525

164views

0downloads

Creation08/12/2022 09:07:00

First validation08/12/2022 09:07:00

Update18/02/2026 08:29:11

Status update18/02/2026 08:29:11

Last indexation18/02/2026 08:32:17

Archive ouverte UNIGE

High antibody titers against apolipoprotein-A1 in NAFLD: a possible link between fatty liver disease and CVD?

Technical informations